Recruiting Hemophilia Studies in Minneapolis
About Hemophilia Clinical Trials in Minneapolis
Hemophilia is a rare genetic bleeding disorder in which blood does not clot properly due to deficiency of clotting factors. Hemophilia A (factor VIII) and hemophilia B (factor IX) are the most common types. Treatment includes factor replacement therapy and newer approaches like gene therapy.
There are currently 1 hemophilia clinical trials recruiting participants in Minneapolis, MN. These studies are seeking a combined 24 participants. Research is being sponsored by Be Biopharma. Clinical trial participation is free and participants receive study-related medical care at no cost.
Hemophilia Clinical Trials in Minneapolis — FAQ
Are there hemophilia clinical trials in Minneapolis?
Yes, there are 1 hemophilia clinical trials currently recruiting in Minneapolis, MN. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Minneapolis?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Minneapolis research site will contact you about next steps.
Are clinical trials in Minneapolis free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Minneapolis studies also compensate for your time and travel.
What hemophilia treatments are being tested?
The 1 active trials in Minneapolis are testing new therapies including novel drugs, biologics, and treatment approaches for hemophilia.
Data updated March 2, 2026 from ClinicalTrials.gov